Supporting consumers as they stop using GLP-1s

For consumers discontinuing GLP-1 therapy, the transition can be fraught with challenges like weight regain, appetite dysregulation and metabolic adaptation. This session focuses on ways that targeted nutrition and supplementation can help former users maintain weight-loss achievements and build metabolic resilience. Attendees will explore formulation strategies for helping consumers support healthy eating and metabolism during this critical period, including ingredients that can aid in balancing indulgence with functionality. With insights into this underserved market segment’s preferences — like heightened sensitivity to taste and texture — participants will gain practical guidance for developing solutions that help consumers successfully navigate life after GLP-1 medications.